NO20014341L - Dissolution of polyunsaturated fatty acids and derivatives thereof by formation of <gamma> cyclodextrin inclusion compositions and their use in pharmaceutical, cosmetic or food compositions - Google Patents
Dissolution of polyunsaturated fatty acids and derivatives thereof by formation of <gamma> cyclodextrin inclusion compositions and their use in pharmaceutical, cosmetic or food compositionsInfo
- Publication number
- NO20014341L NO20014341L NO20014341A NO20014341A NO20014341L NO 20014341 L NO20014341 L NO 20014341L NO 20014341 A NO20014341 A NO 20014341A NO 20014341 A NO20014341 A NO 20014341A NO 20014341 L NO20014341 L NO 20014341L
- Authority
- NO
- Norway
- Prior art keywords
- compositions
- fatty acids
- polyunsaturated fatty
- cosmetic
- dissolution
- Prior art date
Links
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 title abstract 3
- 229920000858 Cyclodextrin Polymers 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 2
- 230000015572 biosynthetic process Effects 0.000 title 1
- 239000002537 cosmetic Substances 0.000 title 1
- 238000004090 dissolution Methods 0.000 title 1
- 235000013305 food Nutrition 0.000 title 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 title 1
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 abstract 4
- 239000000126 substance Substances 0.000 abstract 3
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 abstract 2
- 229940114079 arachidonic acid Drugs 0.000 abstract 2
- 235000021342 arachidonic acid Nutrition 0.000 abstract 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 abstract 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 abstract 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 abstract 2
- 150000003626 triacylglycerols Chemical class 0.000 abstract 2
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 abstract 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 abstract 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 229940013317 fish oils Drugs 0.000 abstract 1
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 abstract 1
- 229940080345 gamma-cyclodextrin Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/738—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/925—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of animal origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
- C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Birds (AREA)
- Polymers & Plastics (AREA)
- Emergency Medicine (AREA)
- Food Science & Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Nanotechnology (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biochemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
Abstract
Hensikten med foreliggende oppfinnelse er en vandig oppløsning som omfatter minst et oljeaktig stoff valgt fra flerumettede fettsyrer og salter, estere og triglyserider av flerumettede fettsyrer, hvor de nevnte stoff(er) er i form av et inklusjonskompleks i y-syklodekstrin.Det oljeaktige stoffet(ene) kan være valgt fra arakidonsyre (AA), eikosapentaensyre (EPA), dokosaheksaensyre (DHA) og triglyserider derav såvel som fra fiskeoljer.The object of the present invention is an aqueous solution comprising at least one oily substance selected from polyunsaturated fatty acids and salts, esters and triglycerides of polyunsaturated fatty acids, wherein said substance (s) is in the form of an inclusion complex in γ-cyclodextrin. The oily substance ( one) may be selected from arachidonic acid (AA), eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and triglycerides thereof as well as from fish oils.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9902881A FR2790758A1 (en) | 1999-03-09 | 1999-03-09 | SOLUBILIZATION OF POLYUNSATURATED FATTY ACIDS AND DERIVATIVES THEREOF BY FORMATION OF INCLUSION COMPLEXES WITH A CYCLODEXTRIN AND THEIR USE IN PHARMACEUTICAL, COSMETIC OR FOOD COMPOSITIONS |
| PCT/FR2000/000560 WO2000053637A1 (en) | 1999-03-09 | 2000-03-07 | INCLUSION COMPLEXES OF POLYUNSATURATED FATTY ACIDS AND THEIR DERIVATIVES WITH η-CYCLODEXTRIN |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20014341D0 NO20014341D0 (en) | 2001-09-06 |
| NO20014341L true NO20014341L (en) | 2001-09-06 |
Family
ID=9542970
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20014341A NO20014341L (en) | 1999-03-09 | 2001-09-06 | Dissolution of polyunsaturated fatty acids and derivatives thereof by formation of <gamma> cyclodextrin inclusion compositions and their use in pharmaceutical, cosmetic or food compositions |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1165620A1 (en) |
| JP (1) | JP2002539138A (en) |
| CA (1) | CA2366719A1 (en) |
| FR (1) | FR2790758A1 (en) |
| NO (1) | NO20014341L (en) |
| WO (1) | WO2000053637A1 (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10253042A1 (en) | 2002-11-14 | 2004-06-03 | Wacker-Chemie Gmbh | Cosmetic preparation containing a complex of cyclodextrin and vitamin F. |
| ES2209658B1 (en) * | 2002-12-05 | 2005-10-01 | Proyecto Empresarial Brudy, S.L. | USE OF DOCOSAHEXAENOIC ACID AS AN ACTIVE PRINCIPLE FOR THE TREATMENT OF LIPODYSTROPHY. |
| FR2850040B1 (en) * | 2003-01-20 | 2005-03-11 | Centre Nat Rech Scient | SYSTEMS FOR MICROENCAPSULATION AND THEIR APPLICATIONS |
| US20040180125A1 (en) * | 2003-03-11 | 2004-09-16 | Plank David W. | Cyclodextrin-containing compositions and methods |
| US7105195B2 (en) * | 2003-07-25 | 2006-09-12 | General Mills, Inc. | Reduced trans fat product |
| US7335386B2 (en) | 2003-07-30 | 2008-02-26 | Gerneral Mills, Inc. | Method for preventing acrylamide formation in food products and food intermediates |
| WO2004112777A1 (en) * | 2003-06-20 | 2004-12-29 | Mochida Pharmaceutical Co., Ltd. | Composition for prevention/treatment for varicose vein |
| WO2008083213A2 (en) * | 2006-12-27 | 2008-07-10 | Cargill, Incorporated | Stabilisation by preparing cyclodextrin inclusion complexes |
| FR2915901A1 (en) * | 2007-05-07 | 2008-11-14 | In Cyclo Soc Par Actions Simpl | HOMOGENEOUS AND STABLE COMPOSITION, RICH IN OLEAGINOUS SUBSTANCES BASED ON A MILK PRODUCT, PROCESS FOR PREPARING SAME AND USES THEREOF. |
| GB0710439D0 (en) * | 2007-05-31 | 2007-07-11 | Uni I Oslo | Oral dosage form |
| GB0808479D0 (en) * | 2008-05-09 | 2008-06-18 | Uni I Oslo | Topical compositions |
| FR3048177B1 (en) * | 2016-02-25 | 2020-10-30 | Fabre Pierre Dermo Cosmetique | BIPHASE COSMETIC COMPOSITION AND ITS USE BY TOPICAL APPLICATION |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5813541A (en) * | 1981-07-16 | 1983-01-26 | Kureha Chem Ind Co Ltd | Cyclodextrin clathrate compound of eicosapentaenoic acid or docosahexaenoic acid |
| JPS5941395A (en) * | 1982-09-01 | 1984-03-07 | マルハ株式会社 | Stabilization of fish oils |
| JPS6034156A (en) * | 1983-08-08 | 1985-02-21 | Hayashibara Biochem Lab Inc | Eicosapentaenoic acid clathrate compound and food and drink containing the same |
| IT1243192B (en) * | 1990-08-09 | 1994-05-24 | Staroil Ltd | LONG CHAIN POLYUNSATURATED FATTY ACIDS AND THEIR DERIVATIVES, WITH CYCLODESTRINE |
| JPH0725816A (en) * | 1993-07-08 | 1995-01-27 | Yoshihisa Matsuda | Polyenoic acid clathrate |
-
1999
- 1999-03-09 FR FR9902881A patent/FR2790758A1/en active Pending
-
2000
- 2000-03-07 EP EP00909441A patent/EP1165620A1/en not_active Withdrawn
- 2000-03-07 WO PCT/FR2000/000560 patent/WO2000053637A1/en not_active Ceased
- 2000-03-07 CA CA002366719A patent/CA2366719A1/en not_active Abandoned
- 2000-03-07 JP JP2000604072A patent/JP2002539138A/en not_active Withdrawn
-
2001
- 2001-09-06 NO NO20014341A patent/NO20014341L/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1165620A1 (en) | 2002-01-02 |
| NO20014341D0 (en) | 2001-09-06 |
| CA2366719A1 (en) | 2000-09-14 |
| JP2002539138A (en) | 2002-11-19 |
| FR2790758A1 (en) | 2000-09-15 |
| WO2000053637A1 (en) | 2000-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Calder | Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases | |
| NO991635L (en) | Pharmaceutical preparation comprising eicospentaenoic acid and / or stearidonic acid | |
| EP1537069A4 (en) | OMEGA-3 PUFAs LIPID MEDIATECTOR ANALOGUES, AND METHODS OF USE | |
| NO20014341L (en) | Dissolution of polyunsaturated fatty acids and derivatives thereof by formation of <gamma> cyclodextrin inclusion compositions and their use in pharmaceutical, cosmetic or food compositions | |
| WO2008036353A3 (en) | Omega-3 diglyceride emulsions | |
| KR940018090A (en) | Triglycerides | |
| NO20026093D0 (en) | Therapeutic combinations of fatty acids | |
| EA200100895A1 (en) | IRRONABLE FATTY ACIDS FOR THE PREVENTION OF CARDIOVASCULAR ACCESSES | |
| KR940018091A (en) | Prescriptions Containing Unsaturated Fatty Acids | |
| NZ734905A (en) | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same | |
| BR0112680A (en) | Elongase genes and uses thereof | |
| IL210233A (en) | Omega-3 fatty acid formulations containing epa and dha and no active ingredients other than omega-3 fatty acids | |
| EP2415360A3 (en) | Use of DPA(n-6) oils in infant formula | |
| EP1698685A4 (en) | Fat composition | |
| JP2008528742A (en) | Production and use of antioxidant extracts from Crypthecodinium | |
| Leray | Introduction to lipidomics: from bacteria to man | |
| RU2009101326A (en) | THE PRODUCT FOR EXTERNAL APPLICATION ON SKIN CONTAINING TRITERPENIC ACID | |
| RU2010103038A (en) | PERSONAL CARE COMPOSITIONS Possessing a weakened irritating effect on the eyes | |
| UY26303A1 (en) | PHARMACEUTICAL COMPOSITIONS FOR ORAL AND TOPICAL ADMINISTRATION | |
| TW360545B (en) | Dermatologic preparation | |
| NO20071180L (en) | Delta 6 desaturase genes and uses thereof | |
| JP2023523020A (en) | Composition for stabilizing isothiocyanates | |
| Calder | Comment on Christiansen et al.: When food met pharma | |
| Lee et al. | Can fish oil dissolve gallstones? | |
| TW201639549A (en) | Combination of a retinoid and a diol and polyunsaturated fatty acid ester |